RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/22843933http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/22843933http://www.w3.org/2000/01/rdf-schema#comment"Recent data suggest that erythropoietin (EPO) plays a substantial role in cancer development and clinical outcome by stimulating cell proliferation, invasion and angiogenesis. A functional polymorphism (rs1617640 G>T) in the promoter region of the EPO gene increases EPO protein expression. In the present study, we investigated the association of EPO rs1617640 G>T with susceptibility and clinical outcome of early-stage breast cancer. Genomic DNA of 539 female patients with histologically confirmed early-stage breast cancer and 804 controls was genotyped for EPO rs1617640 G>T. No association was found between EPO rs1617640 G>T and early-stage breast cancer susceptibility and clinical outcome (hazard ratio=1.24, 95% confidence interval=1.82-1.90, p=0.31). In conclusion, our findings suggest a lack of influence of EPO rs1617640 G>T on early-stage breast carcinogenesis and clinical outcome."xsd:string
http://purl.uniprot.org/citations/22843933http://purl.uniprot.org/core/author"Stotz M."xsd:string
http://purl.uniprot.org/citations/22843933http://purl.uniprot.org/core/author"Renner W."xsd:string
http://purl.uniprot.org/citations/22843933http://purl.uniprot.org/core/author"Samonigg H."xsd:string
http://purl.uniprot.org/citations/22843933http://purl.uniprot.org/core/author"Gerger A."xsd:string
http://purl.uniprot.org/citations/22843933http://purl.uniprot.org/core/author"Langsenlehner T."xsd:string
http://purl.uniprot.org/citations/22843933http://purl.uniprot.org/core/author"Schippinger W."xsd:string
http://purl.uniprot.org/citations/22843933http://purl.uniprot.org/core/author"Winder T."xsd:string
http://purl.uniprot.org/citations/22843933http://purl.uniprot.org/core/author"Szkandera J."xsd:string
http://purl.uniprot.org/citations/22843933http://purl.uniprot.org/core/author"Absenger G."xsd:string
http://purl.uniprot.org/citations/22843933http://purl.uniprot.org/core/author"Weissmueller M."xsd:string
http://purl.uniprot.org/citations/22843933http://purl.uniprot.org/core/date"2012"xsd:gYear
http://purl.uniprot.org/citations/22843933http://purl.uniprot.org/core/name"Anticancer Res"xsd:string
http://purl.uniprot.org/citations/22843933http://purl.uniprot.org/core/pages"3473-3478"xsd:string
http://purl.uniprot.org/citations/22843933http://purl.uniprot.org/core/title"The functional polymorphism of erythropoietin gene rs1617640 G>T is not associated with susceptibility and clinical outcome of early-stage breast cancer."xsd:string
http://purl.uniprot.org/citations/22843933http://purl.uniprot.org/core/volume"32"xsd:string
http://purl.uniprot.org/citations/22843933http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/22843933
http://purl.uniprot.org/citations/22843933http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/22843933
http://purl.uniprot.org/uniprot/#_B7ZKK5-mappedCitation-22843933http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22843933
http://purl.uniprot.org/uniprot/#_G9JKG7-mappedCitation-22843933http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22843933
http://purl.uniprot.org/uniprot/#_T2DKX4-mappedCitation-22843933http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22843933
http://purl.uniprot.org/uniprot/#_P01588-mappedCitation-22843933http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22843933
http://purl.uniprot.org/uniprot/#_U3MHQ9-mappedCitation-22843933http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22843933
http://purl.uniprot.org/uniprot/T2DKX4http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/22843933